Loading...

Gary J Schiller

Title(s)Professor-in-Residence, Medicine
SchoolMedicine
Address760 Westwood Plaza 32-144
Los Angeles CA 90024
Phone65755
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Addressing the Measles-Mumps-Rubella Revaccination Guidelines for Allogenic Bone Marrow Transplant Patients: A Response to the American Society for Transplantation and Cellular Therapy 2019 Position Statement. Biol Blood Marrow Transplant. 2020 07; 26(7):e171-e172. Perez K, Shah VV, Schiller GJ. PMID: 32209395.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Durable Survival Outcomes in Primary and Secondary Central Nervous System Lymphoma After High-dose Chemotherapy and Autologous Stem Cell Transplantation Using a Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen. Clin Lymphoma Myeloma Leuk. 2020 Jul; 20(7):468-479. Young PA, Gaut D, Kimaiyo DK, Grotts J, Romero T, Chute J, Schiller G, de Vos S, Eradat HA, Timmerman J. PMID: 32229199.
      View in: PubMed   Mentions:    Fields:    
    3. Venetoclax combination therapy in relapsed/refractory acute myeloid leukemia: A single institution experience. Leuk Res. 2020 03; 90:106314. Gaut D, Burkenroad A, Duong T, Feammelli J, Sasine J, Schiller G. PMID: 32035355.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    4. Chronic myeloid leukemia stem cells require cell-autonomous pleiotrophin signaling. J Clin Invest. 2020 01 02; 130(1):315-328. Himburg HA, Roos M, Fang T, Zhang Y, Termini CM, Schlussel L, Kim M, Pang A, Kan J, Zhao L, Suh H, Sasine JP, Sapparapu G, Bowers PM, Schiller G, Chute JP. PMID: 31613796.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    5. How to address second and therapy-related acute myelogenous leukaemia. Br J Haematol. 2020 01; 188(1):116-128. Oliai C, Schiller G. PMID: 31863469.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Disease characteristics of diffuse large B-cell lymphoma predicting relapse and survival after autologous stem cell transplantation: A single institution experience. Hematol Oncol. 2020 Feb; 38(1):38-50. Gaut D, Romero T, Oveisi D, Howell G, Schiller G. PMID: 31674036.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    7. Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma. N Engl J Med. 2019 08 22; 381(8):727-738. Chari A, Vogl DT, Gavriatopoulou M, Nooka AK, Yee AJ, Huff CA, Moreau P, Dingli D, Cole C, Lonial S, Dimopoulos M, Stewart AK, Richter J, Vij R, Tuchman S, Raab MS, Weisel KC, Delforge M, Cornell RF, Kaminetzky D, Hoffman JE, Costa LJ, Parker TL, Levy M, Schreder M, Meuleman N, Frenzel L, Mohty M, Choquet S, Schiller G, Comenzo RL, Engelhardt M, Illmer T, Vlummens P, Doyen C, Facon T, Karlin L, Perrot A, Podar K, Kauffman MG, Shacham S, Li L, Tang S, Picklesimer C, Saint-Martin JR, Crochiere M, Chang H, Parekh S, Landesman Y, Shah J, Richardson PG, Jagannath S. PMID: 31433920.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    8. Identifying risk factors associated with worse outcomes in adolescents and young adults undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2019 12; 66(12):e27940. Friend BD, Tang K, Markovic D, Elashoff D, Moore TB, Schiller GJ. PMID: 31429528.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Autoimmune hemolytic anemia in refractory hairy cell leukemia on dabrafenib and trametinib. Ann Hematol. 2019 Oct; 98(10):2443-2445. Ng DB, Schiller G, Ha E. PMID: 31410508.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Cardiac Complications in the Adult Bone Marrow Transplant Patient. Curr Oncol Rep. 2019 03 02; 21(3):28. Tuzovic M, Mead M, Young PA, Schiller G, Yang EH. PMID: 30826891.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Hematopoietic stem cell transplantation in primary central nervous system lymphoma: a review of the literature. Int J Hematol. 2019 Mar; 109(3):260-277. Gaut D, Schiller GJ. PMID: 30671909.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Liposomal Cytarabine-Daunorubicin (CPX-351) Extravasation: Case Report and Literature Review. Anticancer Res. 2018 Dec; 38(12):6927-6930. Howell G, Oliai C, Schiller G. PMID: 30504411.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients With Acute Myeloid Leukemia. Curr Treat Options Oncol. 2018 10 25; 19(12):63. Levin-Epstein R, Oliai C, Schiller G. PMID: 30362051.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    14. High-Dose Vincristine Sulfate Liposome Injection, for Advanced, Relapsed, or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in an Adolescent and Young Adult Subgroup of a Phase 2 Clinical Trial. J Adolesc Young Adult Oncol. 2018 10; 7(5):546-552. Schiller GJ, Damon LE, Coutre SE, Hsu P, Bhat G, Douer D. PMID: 30239252.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    15. CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia. J Clin Oncol. 2018 09 10; 36(26):2684-2692. Lancet JE, Uy GL, Cortes JE, Newell LF, Lin TL, Ritchie EK, Stuart RK, Strickland SA, Hogge D, Solomon SR, Stone RM, Bixby DL, Kolitz JE, Schiller GJ, Wieduwilt MJ, Ryan DH, Hoering A, Banerjee K, Chiarella M, Louie AC, Medeiros BC. PMID: 30024784.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCTClinical Trials
    16. Response. Biol Blood Marrow Transplant. 2018 09; 24(9):1953-1954. Molina A, Winston DJ, Pan D, Schiller GJ. PMID: 29909155.
      View in: PubMed   Mentions:    Fields:    
    17. Phase 2b study of 2 dosing regimens of quizartinib monotherapy in FLT3-ITD-mutated, relapsed or refractory AML. Blood. 2018 08 09; 132(6):598-607. Cortes JE, Tallman MS, Schiller GJ, Trone D, Gammon G, Goldberg SL, Perl AE, Marie JP, Martinelli G, Kantarjian HM, Levis MJ. PMID: 29875101.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCellsCTClinical Trials
    18. The Slippery Slope of Legalization of Physician-Assisted Suicide. Ann Intern Med. 2018 05 01; 168(9):683. PMID: 29710259.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Gene Therapy in Patients with Transfusion-Dependent ß-Thalassemia. N Engl J Med. 2018 04 19; 378(16):1479-1493. Thompson AA, Walters MC, Kwiatkowski J, Rasko JEJ, Ribeil JA, Hongeng S, Magrin E, Schiller GJ, Payen E, Semeraro M, Moshous D, Lefrere F, Puy H, Bourget P, Magnani A, Caccavelli L, Diana JS, Suarez F, Monpoux F, Brousse V, Poirot C, Brouzes C, Meritet JF, Pondarré C, Beuzard Y, Chrétien S, Lefebvre T, Teachey DT, Anurathapan U, Ho PJ, von Kalle C, Kletzel M, Vichinsky E, Soni S, Veres G, Negre O, Ross RW, Davidson D, Petrusich A, Sandler L, Asmal M, Hermine O, De Montalembert M, Hacein-Bey-Abina S, Blanche S, Leboulch P, Cavazzana M. PMID: 29669226.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCellsCTClinical Trials
    20. Secondary clonal hematologic neoplasia following successful therapy for acute promyelocytic leukemia (APL): A report of two cases and review of the literature. Leuk Res Rep. 2018; 9:65-71. Gaut D, Sasine J, Schiller G. PMID: 29892552.
      View in: PubMed   Mentions:
    21. Increased Incidence of Nocardial Infections in an Era of Atovaquone Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Biol Blood Marrow Transplant. 2018 08; 24(8):1715-1720. Molina A, Winston DJ, Pan D, Schiller GJ. PMID: 29555315.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Recurrent heart failure with preserved ejection fraction associated with carfilzomib administration for multiple myeloma. Cardiooncology. 2018; 4:2. Yang EH, Courtney C, Garg V, Fradley MG, Schiller GJ. PMID: 32154003.
      View in: PubMed   Mentions:
    23. Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma. J Clin Oncol. 2018 03 20; 36(9):859-866. Vogl DT, Dingli D, Cornell RF, Huff CA, Jagannath S, Bhutani D, Zonder J, Baz R, Nooka A, Richter J, Cole C, Vij R, Jakubowiak A, Abonour R, Schiller G, Parker TL, Costa LJ, Kaminetzky D, Hoffman JE, Yee AJ, Chari A, Siegel D, Fonseca R, Van Wier S, Ahmann G, Lopez I, Kauffman M, Shacham S, Saint-Martin JR, Picklesimer CD, Choe-Juliak C, Stewart AK. PMID: 29381435.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    24. Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation. Biol Blood Marrow Transplant. 2018 05; 24(5):945-955. Bejanyan N, Zhang MJ, Wang HL, Lazaryan A, de Lima M, Marks DI, Sandmaier BM, Bachanova V, Rowe J, Tallman M, Kebriaei P, Kharfan-Dabaja M, Peter Gale R, Lazarus HM, Ustun C, Copelan E, Ky Hamilton B, Schiller G, Hogan W, Hashmi S, Seftel M, Kanakry CG, Olsson RF, Martino R, Saber W, Khoury HJ, Weisdorf DJ. PMID: 29275139.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Closing the gap: Novel therapies in treating acute lymphoblastic leukemia in adolescents and young adults. Blood Rev. 2018 03; 32(2):122-129. PMID: 28969872.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study. Lancet Oncol. 2017 08; 18(8):1061-1075. PMID: 28645776.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansCellsCTClinical Trials
    27. Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis. Biol Blood Marrow Transplant. 2017 May; 23(5):853-856. PMID: 28161608.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    28. Novel Cytogenetic Findings in a Case of Mixed Phenotype Acute Leukemia within the Context of a Complex Karyotype. J Assoc Genet Technol. 2017; 43(1):20-22. PMID: 28459703.
      View in: PubMed   Mentions:
    29. Acute Myeloid Leukemia: How Do We Measure Success? Curr Hematol Malig Rep. 2016 12; 11(6):528-536. PMID: 27604228.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    30. A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature. Biomark Res. 2016; 4(1):16. PMID: 27570624.
      View in: PubMed   Mentions:
    31. Preventive strategies for invasive Aspergillus in acute myelogenous leukemia. Clin Adv Hematol Oncol. 2016 May; 14(5):324-5. PMID: 27379692.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    32. Allogeneic Hematopoietic Stem Cell Transplantation in FLT3-ITD-Positive Acute Myelogenous Leukemia: The Role for FLT3 Tyrosine Kinase Inhibitors Post-Transplantation. Biol Blood Marrow Transplant. 2016 06; 22(6):982-990. PMID: 26785334.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    33. High-Intensity Induction in the Elderly. Acta Haematol. 2016; 135(1):53-4. PMID: 26444244.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    34. New cancers after autotransplantations for multiple myeloma. Biol Blood Marrow Transplant. 2015 Apr; 21(4):738-45. PMID: 25555448.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    35. Emerging strategies for high-risk and relapsed/refractory acute myeloid leukemia: novel agents and approaches currently in clinical trials. Blood Rev. 2015 Jan; 29(1):1-9. PMID: 25441922.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    36. An exploratory phase 2 study of investigational Aurora A kinase inhibitor alisertib (MLN8237) in acute myelogenous leukemia and myelodysplastic syndromes. Leuk Res Rep. 2014; 3(2):58-61. PMID: 25068104.
      View in: PubMed   Mentions:
    37. Evolving treatment strategies in patients with high-risk acute myeloid leukemia. Leuk Lymphoma. 2014 Nov; 55(11):2438-48. PMID: 24432896.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Allogeneic transplantation as therapy for acute myelogenous leukemia in the elderly. Biol Blood Marrow Transplant. 2014 Apr; 20(4):437-8. PMID: 24487045.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Myelodysplasia. Hematology. 2013 Sep; 18(5):307-8. PMID: 24020490.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. High-dose cytarabine (HD araC) in the treatment of leukemias: a review. Curr Hematol Malig Rep. 2013 Jun; 8(2):141-8. PMID: 23666364.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    41. Salvage second hematopoietic cell transplantation in myeloma. Biol Blood Marrow Transplant. 2013 May; 19(5):760-6. PMID: 23298856.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    42. High-risk acute myelogenous leukemia: treatment today ... and tomorrow. Hematology Am Soc Hematol Educ Program. 2013; 2013:201-8. PMID: 24319182.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    43. Secondary hemophagocytic lymphohistiocytosis in adults: an update on diagnosis and therapy. Clin Adv Hematol Oncol. 2012 Nov; 10(11):726-32. PMID: 23271259.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    44. Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research. Haematologica. 2013 Feb; 98(2):185-92. PMID: 22983587.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    45. Minimal residual disease as a predictive factor for relapse after allogeneic hematopoietic stem cell transplant in adult patients with acute myeloid leukemia in first and second complete remission. Cancers (Basel). 2012 Jun 20; 4(2):601-17. PMID: 24213327.
      View in: PubMed   Mentions:
    46. Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial. J Clin Oncol. 2012 Jul 10; 30(20):2492-9. PMID: 22585697.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCTClinical Trials
    47. Blastic plasmacytoid dendritic cell neoplasm. Clin Adv Hematol Oncol. 2012 Jan; 10(1):60-2. PMID: 22398811.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    48. Transplantation for congenital bone marrow failure syndromes. Bone Marrow Res. 2011; 2011:849387. PMID: 22046571.
      View in: PubMed   Mentions:
    49. When a gold standard is made of tin. Blood. 2010 Nov 25; 116(22):4386-7. Schiller GJ. PMID: 21109621.
      View in: PubMed   Mentions: 2     Fields:    
    50. Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3. J Clin Oncol. 2010 Oct 01; 28(28):4339-45. Fischer T, Stone RM, Deangelo DJ, Galinsky I, Estey E, Lanza C, Fox E, Ehninger G, Feldman EJ, Schiller GJ, Klimek VM, Nimer SD, Gilliland DG, Dutreix C, Huntsman-Labed A, Virkus J, Giles FJ. PMID: 20733134.
      View in: PubMed   Mentions: 170     Fields:    Translation:HumansCTClinical Trials
    51. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol. 2010 Aug 10; 28(23):3730-8. Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM, Kamble R, Copelan E, de Lima M, Gupta V, Keating A, Lazarus HM, Litzow MR, Marks DI, Maziarz RT, Rizzieri DA, Schiller G, Schultz KR, Tallman MS, Weisdorf D. PMID: 20625136.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansCTClinical Trials
    52. Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2011 Apr; 17(4):507-15. Winston DJ, Bartoni K, Territo MC, Schiller GJ. PMID: 20460163.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    53. Outcome of transplantation for myelofibrosis. Biol Blood Marrow Transplant. 2010 Mar; 16(3):358-67. Ballen KK, Shrestha S, Sobocinski KA, Zhang MJ, Bashey A, Bolwell BJ, Cervantes F, Devine SM, Gale RP, Gupta V, Hahn TE, Hogan WJ, Kröger N, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Schiller G, Schouten HC, Roy V, Wiernik PH, Horowitz MM, Giralt SA, Arora M. PMID: 19879949.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    54. Current status of acute myeloid leukemia treatment in the elderly. Clin Adv Hematol Oncol. 2009 Sep; 7(9):580-2. Schiller G. PMID: 20020668.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    55. Myelodysplastic syndrome: An update on diagnosis and therapy. Curr Hematol Malig Rep. 2009 Jan; 4(1):10-6. Koppel A, Schiller G. PMID: 20425433.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    56. The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood. 2009 Mar 26; 113(13):3110-8. Ringdén O, Pavletic SZ, Anasetti C, Barrett AJ, Wang T, Wang D, Antin JH, Di Bartolomeo P, Bolwell BJ, Bredeson C, Cairo MS, Gale RP, Gupta V, Hahn T, Hale GA, Halter J, Jagasia M, Litzow MR, Locatelli F, Marks DI, McCarthy PL, Cowan MJ, Petersdorf EW, Russell JA, Schiller GJ, Schouten H, Spellman S, Verdonck LF, Wingard JR, Horowitz MM, Arora M. PMID: 19059878.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    57. Comparison of twin and autologous transplants for multiple myeloma. Biol Blood Marrow Transplant. 2008 Oct; 14(10):1118-1124. Bashey A, Pérez WS, Zhang MJ, Anderson KC, Ballen K, Berenson JR, To LB, Fonseca R, Freytes CO, Gale RP, Gibson J, Giralt SA, Kyle RA, Lazarus HM, Maharaj D, McCarthy PL, Milone GA, Nimer S, Pavlovsky S, Reece DE, Schiller G, Vesole DH, Hari P. PMID: 18804041.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    58. Myelodysplastic syndrome: an update on diagnosis and therapy. Curr Oncol Rep. 2008 Sep; 10(5):372-8. Koppel A, Schiller G. PMID: 18706264.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    59. Acute myeloid leukemia in the elderly: conventional and novel treatment approaches. Blood Rev. 2008 Jul; 22(4):221-34. Craig CM, Schiller GJ. PMID: 18433953.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    60. Standardized protocol to identify high-risk patients undergoing therapeutic apheresis procedures. J Clin Apher. 2008; 23(3):111-5. Lu Q, Nedelcu E, Ziman A, Bumerts P, Fernando L, Schiller G. PMID: 18521857.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    61. Exclusive use of acid citrate dextrose for anticoagulation during extracorporeal photopheresis in patients with contraindications to heparin: an effective protocol. J Clin Apher. 2008; 23(2):66-73. Nedelcu E, Ziman A, Fernando LP, Cook K, Bumerts P, Schiller G. PMID: 18286495.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells. . 2007 Nov; 6(11):2995-3008. Daniels TR, Ng PP, Delgado T, Lynch MR, Schiller G, Helguera G, Penichet ML. PMID: 18025284.
      View in: PubMed   Mentions:
    63. Duodenal lymphoma: a rare and morbid tumor. Am Surg. 2007 Oct; 73(10):1057-62. Chestovich PJ, Schiller G, Sasu S, Hiatt JR. PMID: 17983081.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    64. Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromes. J Clin Oncol. 2006 Jun 01; 24(16):2456-64. Schiller GJ, Slack J, Hainsworth JD, Mason J, Saleh M, Rizzieri D, Douer D, List AF. PMID: 16651647.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    65. Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of patients > or =60 years with acute myelogenous leukemia. Biol Blood Marrow Transplant. 2006 Apr; 12(4):466-71. Lashkari A, Lowe T, Collisson E, Paquette R, Emmanouilides C, Territo M, Schiller G. PMID: 16545730.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    66. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. Biol Blood Marrow Transplant. 2006 Feb; 12(2):204-16. Tallman MS, Pérez WS, Lazarus HM, Gale RP, Maziarz RT, Rowe JM, Marks DI, Cahn JY, Bashey A, Bishop MR, Christiansen N, Frankel SR, García JJ, Ilhan O, Laughlin MJ, Liesveld J, Linker C, Litzow MR, Luger S, McCarthy PL, Milone GA, Pavlovsky S, Phillips GL, Russell JA, Saez RA, Schiller G, Sierra J, Weiner RS, Zander AR, Zhang MJ, Keating A, Weisdorf DJ, Horowitz MM. PMID: 16443518.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    67. Myelodysplasic syndromes: a comprehensive review. Blood Rev. 2005 Nov; 19(6):301-19. Catenacci DV, Schiller GJ. PMID: 15885860.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    68. Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain. Blood. 2006 Jan 01; 107(1):293-300. Heidel F, Solem FK, Breitenbuecher F, Lipka DB, Kasper S, Thiede MH, Brandts C, Serve H, Roesel J, Giles F, Feldman E, Ehninger G, Schiller GJ, Nimer S, Stone RM, Wang Y, Kindler T, Cohen PS, Huber C, Fischer T. PMID: 16150941.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansCells
    69. The evolution of antibodies into versatile tumor-targeting agents. Clin Cancer Res. 2005 Jan 01; 11(1):129-38. Lin MZ, Teitell MA, Schiller GJ. PMID: 15671537.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    70. Identification of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute myeloid leukemia (AML). Blood. 2005 Jan 01; 105(1):335-40. Kindler T, Breitenbuecher F, Kasper S, Estey E, Giles F, Feldman E, Ehninger G, Schiller G, Klimek V, Nimer SD, Gratwohl A, Choudhary CR, Mueller-Tidow C, Serve H, Gschaidmeier H, Cohen PS, Huber C, Fischer T. PMID: 15345593.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    71. Re: allogenic transplantation after nonmyelosuppressive conditioning--the effect of single-agent pentostatin. Biol Blood Marrow Transplant. 2004 Aug; 10(8):576-7. Schiller GJ, Malone R, Figlin R. PMID: 15328623.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    72. Pilot study of fixed-infusion rate gemcitabine with Cisplatin and dexamethasone in patients with relapsed or refractory lymphoma. Clin Lymphoma. 2004 Jun; 5(1):45-9. Emmanouilides C, Colovos C, Pinter-Brown L, Hernandez L, Schiller G, Territo M, Rosen P. PMID: 15245607.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    73. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003 Apr 01; 101(7):2461-3. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. PMID: 12433676.
      View in: PubMed   Mentions: 353     Fields:    Translation:HumansCells
    74. Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin Infect Dis. 2002 Jun 15; 34(12):1648-50. Mellinghoff IK, Winston DJ, Mukwaya G, Schiller GJ. PMID: 12032903.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimals
    Gary's Networks
    Concepts (295)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (17)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑